Clinical Utility of an Age, Sex, and Gene Expression Score (ASGES or Corus CAD) in African American Patients.

Completed

Conditions studied: Coronary Artery Disease, Angina Pectoris, Chest Pain, Cardiovascular Diseases, Coronary Heart Disease, CHD, CVD, CAD

In brief

This is a retrospective study, designed to be conducted at a single-center in the US. The study will conduct a one-time data abstraction from approximately 500 patient medical charts who received Age/Sex/Gene Expression score (ASGES) also knows as Corus CAD testing, by order of the Principal Investigator. Limited demographic data and patient data pertaining to cardiology referral or advanced diagnostic testing will be collected. All data will be collected anonymously.

Key facts

Study ID

NCT02405754

Run by

CardioDx

People needed

667

Starts

2014-02-01

Expected to finish

2014-08-01

Last updated by the study team

2019-01-31

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients receiving Corus CAD (ASGES) from 2008-2012.

You may not qualify if…

• If any of the following co-moribidities, medical conditions, or current medical statuses are noted in the patient medical chart, s/he will be excluded from the analysis dataset:
• History of diabetes;
• Revascularization or myocardial infarction;
• Systemic infection or inflammatory condition; or
• Use of steroids, immunosuppressive agents, or chemotherapeutic agents.

Where it is running

• Providence Medical Group - Dayton Primary — Dayton, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.